Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q4 2013 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$15.18K$15.18Kderived+46.0% vs Q4 2012 Net Income-$564.05K-$564.05KderivedN/M vs Q4 2012 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$9,089+173.6% Operating Incomederived-$666,161N/M Operating Cash Flowderived-$221,045N/M Margins · derivedGross margin59.9%+27.9 pt vs Q4 2012
Operating margin-4387.8%+10604.1 pt vs Q4 2012
Net margin-3715.2%+12837.5 pt vs Q4 2012
ended Dec 31, 2013 · filed Apr 1, 2014 · 91 d after period end